Instructions and Guidlines

Aims and Scope

Infectious Diseases & Immunity (IDI) is an open access, peer-reviewed journal. It is supervised by Chinese Association for Science and Technology, sponsored by Chinese Medical Association, and published in collaboration with Wolters Kluwer.

IDI covers the types of Original Article (Basic or Clinical), Consensus and Guideline, Commentary, Editorial, Review, Short Report & Case Report, Research Letter, Perspective, etc. The journal focuses on the new developments in basic and clinical researches in the diagnosis and treatment of infectious diseases and related immunology. It aims to provide a platform of timely academic exchanges and information transmission for scientists and clinical experts in related fields around the world.

Types of manuscripts published

 

Type	Text Word Guideline*	Abstract Word Guideline	Figure/Table Guideline	Reference Guideline	Supplement Possible
Editorial	1500	No requirements	1	20	No
Consensus and Guideline	No requirements	No requirements	No requirements	No requirements	No
Perspective	1500	No requirements	No requirements	No requirements	Yes
Original Article	5000	500 words maximum, with sub-headers.	No limit, but 8 figures should be sufficient	No limit	Yes
Review	5000	500 words maximum, unstructured	Minimum 1 image or figure.	No limit	No
Research Letter	500	No requirements	1	4	Yes
Commentary	1500	No requirements	2	20	No
Short Report & Case Report	1500	200 words maximum, unstructured	4	20	Yes

 

*Text word count excludes abstract, figure legends, and references. Please ensure that the text word count is included on the Title page of the manuscript.

Editorials are invited articles to explain the importance of specific articles or to provide opinions on general concepts in practice, research or policy. Editorials have no abstract and are typically 1000 to 1500 words long. Editorials which discuss a recently published article should cite that article as the first reference.

Consensuses and Guidelines are official recommendations from professional organizations on issues related to clinical practice and health care delivery. IDI is flexible with length, reference, and other format requirements given the variability in the format of guidelines developed by different organizations. A concise table or concise graphic summarizing the recommendations and other key points is desirable. Guidelines that meet standards (http://www.equator-network.org/) will fare more favorably than those that do not.

Perspectives are welcomed and the length should be about 1500 words (not including tables, figures, and references). Authors of this type of articles should sign their real names; no anonymous pieces are published.

Original Articles are full-length reports of completed basic, translational or clinical research. Articles should report important, novel and fully completed studies with strong conclusions.

Reviews are comprehensive analyses of specific topics. They are submitted upon invitation by the Editors. Proposals for reviews may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration. Both solicited and unsolicited review articles will undergo peer review prior to acceptance.

Research Letters must offer perspective to content published in IDI. A Research Letter must reference the original source, and a Response to a Letter must reference the Letter in the first few paragraphs. Letters can use an arbitrary title, but a Response must cite the title of the Letter: e.g. Response to [title of Letter]. This ensures that readers can track the line of discussion. Submissions may be edited for length, grammatical correctness, and journal style. Authors will be asked to approve editorial changes that alter the substance or tone of a letter or response.

Commentaries, upon Editor's invitation, discuss a paper published in a specific issue and should set the problems addressed by the paper in the wider context of the field. Proposals for Commentaries may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration including the article discussed.

Short Reports & Case Reports cover new observations of diseases, clinical findings or novel/unique treatment outcomes relevant to practitioners in infectious diseases and immunity research. The text should be arranged as follows: Abstract, Introduction, Case Report, and Discussion. Only cases of exceptional interest and novelty are considered. For manuscripts that do not qualify, Editors may ask authors to shorten manuscripts and rewrite as Letters to the Editor.

Manuscript preparation and formatting instructions

Please double space the entire main body document and number each page. Do not add line numbers as the system will generate those when the PDF is built Acceptable document file types for text and tables include .DOC and .DOCX; do not submit a PDF.

Cover Letter: The cover letter must state that the manuscript has not been and will not be considered for publication elsewhere and give a brief introduction to the novel findings of this work, along with three or more experts in the field as potential reviewers, but no more than three excluded referees.

Title Page: The Title Page must be a separate file and upload separately to the main body file. The following elements are required for every submission.

· Type of manuscript. Editorial, Consensus and Guideline, Perspective, Original Article, Review, Research Letter, Commentary, Case Report.

· Title. Include a descriptive title of the work; the title should not be a sentence. No proprietary or brand names for drugs or agents may be used in article titles.

· Authors. The full first name, middle initials, and family name of each author, as well as the name(s) of the department(s) and institution(s) to which the work should be attributed.

· Correspondence. A current email for the corresponding author must be provided.

· Text word count. Text word count excludes abstract, figure legends, and references.

Abstract: Where required, abstracts are limited to 500 words, which are excluded from the overall manuscript word count. The abstract should briefly describe: (1) the problem being addressed in the study, (2) how the study was performed, (3) the salient results, and (4) what the authors conclude from the results.

Key Words: Minimum 3 keywords needed; three to six keywords.

Introduction: The introduction contains a statement of the purpose of the work, the problem that it stimulated, and a brief summary of relevant published investigations.

Materials and Methods: Avoid detailed description of previously published methods and cite the appropriate reference. Detailed methods may be provided as Supplementary information.

Results: The results should be concise, avoiding redundant tables and figures illustrating the same data.

Discussion: This section should follow the results and is used to interpret results, with minimal recapitulation of findings.

Statistics: Whenever possible quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Authors should report losses to observation (such as dropouts from a clinical trial). When data are summarized in the Results section, specify the statistical methods used to analyze them. Avoid non-technical uses of technical terms in statistics, such as ‘random' (which implies a randomizing device), ‘normal', ‘significant', ‘correlations', and ‘sample'. Define statistical terms, abbreviations, and most symbols. Specify the computer software used. Use upper italics (e.g., P=0.048). For all P values include the exact value and not less than 0.05 or 0.01. Mean differences in continuous variables, proportions in categorical variables and relative risks including odds ratios and hazard ratios should be accompanied by their confidence intervals.

Acknowledgments: This section normally includes sources of research funds, the names of collaborators who are not listed as coauthors, or of any others who contributed to the manuscript. Where a medical writer or editorial assistant has been used to write or edit the article, the writer must be identified and named, together with the source of funding.

Funding: Include disclosure of funding received for this work, especially details of funding from any of the following organizations: National Institutes of Health (NIH); Wellcome Trust; and Howard Hughes Medical Institute (HHMI).

Author contributions: List each author's specific contributions to the work (see details below, under (Authorship).

Conflicts of Interest: List any potential conflict of interest for each author, or make a declaration of "None"

References: Authors are responsible for the accuracy and completeness of their references and for correct citation of the text. References should be numbered consecutively in the order in which they are first mentioned in the text (not in alphabetic order). Identify references in text, tables, and legends by Arabic numerals within square brackets in superscript after the punctuation marks. References cited only in tables or figure legends should be numbered in accordance with the sequence established by the first identification in the text of the particular table or figure. Use the style of the examples below, which are based on the Vancouver formats. The titles of journals should be abbreviated according to the style used in Index Medicus. Use complete name of the journal for non-indexed journals. Avoid using abstracts as references. Avoid citing a “personal communication” unless it provides essential information not available from a public source, in which case the name of the person and date of communication should be cited in parentheses in the text.

Note: from January 2016, the available Digital Object Identifier (DOI) should be added at the end of every reference.

Examples of journal citations

1. Meng FG, Jia FM, Ren XH, Ge Y, Wang KL, Ma YS, et al. Vagus Nerve Stimulation for Pediatric and Adult Patients with Pharmaco-resistant Epilepsy. Chin Med J 2015; 128(19):2599-2604. doi: 10.4103/0366-6999.166023.

     2. Wang YS, Miao LY, Liu L, Cai HR, Ding JJ, Ren SX, et al. Serum cytokine levels in patients with advanced non-small cell lung cancer: Correlation with clinical outcome of erlotinib treatment. Chin Med J 2013; 126(20): 3931-3935. doi: 10.3760/cma.j.issn.0366-6999.20130578

Example of a book citation

1. Weinstein L, Swartz MN. Pathogenic properties of invading microorganisms. In: Sodeman WA Jr., Sodeman WA, eds. Pathologic physiology: mechanisms of disease. Philadelphia: Saunders; 1974: 457-472.

     2. Anderson SC, Poulsen KB. Anderson’s electronic atlas of hematology. Philadelphia: Lippincott Williams & Wilkins, 2002.

Example of Electronic Sources citation

1. Cumulative number of reported cases of severe acute respiratory syndrome (SARS). Geneva: World Health Organization, 2003. Available from:
http://www.who.int/csr/sarscountry/2003_04_04/en/. Accessed April 9, 2003.

Tables: Photographs of tables are not acceptable. Type each table, 1.5 spacing throughout (including column headings, footnotes, and data), on a separate page. Tables may be included as part of the Main Body file and placed after the References section. Number the tables in sequence in Arabic numerals and supply a concise, informative title for each one. Each column in the tables should carry a concise heading describing the data in the column. Use lowercase superscript letters to designate footnotes, and type the footnotes below the tables to which they refer. Tables are cited in the text in numerical order. Each table should be able to be understood without consulting the text.

Like text, tables should be prepared using a standard word-processing program and may be included within the main body text document, or uploaded separately. Do not upload table files more than once (that is, in the main document and in separate files).

Acceptable document file types for tables include .DOC and .DOCX; do not submit PDF, XLS or XLSX type files.

Figures and Legends: Figures should be uploaded in the highest resolution available. Legends should be supplied for all figures. They are numbered to correspond with the figures and typed double-spaced on a separate page. Figure legends for any supplemental figures being submitted are to be provided separately; see section, Supplemental Digital Content (SDC).

Acceptable figure file formats: Do not embed figures into the main body file.

· All final digital figures for accepted manuscripts must be submitted in EPS, TIFF, JPG. PowerPoint PPT format is permitted when the image resolution is very high.

· Each figure must be uploaded as a separate file.

· Histology figures must be in color.

· Monochrome images (such as line graphs) should be prepared at a resolution of 1200 DPI.

· Halftones images (black/white or color) should be prepared at a resolution of 300 DPI.

· Combination halftones (images containing both pictures and text labeling) should be prepared at 600 DPI.

· Color images must be saved as "CMYK". Images saved as "RGB" are not acceptable for printing.

Your manuscript may be returned to you for correction if the images are of insufficient quality.

Artwork submitted to the Journal will be checked for quality. Authors submitting a revised paper will have the opportunity to check the quality of their images and make the necessary changes. This step is required for all revisions.

Supplemental Digital Content (SDC): Authors may submit Supplemental Digital Content to supplement the information provided in the manuscript. It is preferable to include all significant figures and tables in the manuscript. Nonetheless, SDC may include the following types of content: text, tables, figures, references peripheral to information provided as SDC, audio, and video. SDC should be consecutively cited in the Main Body text of the submitted manuscript. SDC files will be available via url(/s) placed at the citation points within the article and are not copyedited by the publisher. Note that Journal policies for manuscript submission relating to peer review, patient anonymity, ethics, financial disclosure, copyright, and permissions also apply to SDC. Authors should mask patients' eyes and remove patients' names from supplemental digital content unless they obtain written consent from the patients and submit them as supplemental files at the time of the manuscript submission.

Format, File Type and Size Requirements: SDC must be provided in one Word or PowerPoint file. Each SDC in the file should have a visual header in the following name format (e.g., "SDC, Figure 1"; "SDC, Materials and Methods") and a corresponding citation must appear in the Main Body text. Note that SDC is numbered separately from non-SDC material. If providing SDC figure(s), a figure legend should be included on the figure itself. When uploading SDC select "Supplemental Digital Content" as the file designation. For audio and video files, also include the author name, videographer, participants, length (minutes), and size (MB). Video files should be formatted with a 320x240 pixel minimum screen size. For each submission, the SDC file cannot exceed a total size of 10 MB.

Checklist

You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Instructions for Authors for more details.

Cover letter

· Signed by all contributors;

· Previous publication/presentations mentioned;

· Source of funding mentioned;

· Conflicts of interest disclosed.

Authors

· Last name and given name provided along with Middle name initials (where applicable);

· Author for correspondence, with E-mail address provided;

· Identity not revealed in paper except title page (e.g., name of the institute in Methods, citing previous study as "our study", names on figure labels, name of institute in photographs, etc.).

Presentation and format

· Use only 10- or 12-point font size;

· Page numbers included at the bottom;

· Title page contains all the desired information;

· Abstract page contains the full title of the manuscript;

· Abstract provided (structured abstract of 500 words for original articles [Background, Methods, Results, Conclusions] and unstructured abstract for review articles, short report & case report);

· Key words provided (three to six words). Introduction should be short and arresting. State the purpose of the article and summarize the rationale for the study or observation. Give only strictly pertinent references;

· The references cited in the text should be after punctuation marks;

· References according to the journal's instructions, punctuation marks checked;

· Send the article file without "Track Changes".

Language and grammar

· Uniformly American English;

· Write the full term for each abbreviation at its first use in the title, abstract, keywords and text separately unless it is a standard unit of measure. Numerals from 1 to 10 spelled out;

· Numerals at the beginning of the sentence spelled out;

· Check the manuscript for spelling, grammar, and punctuation errors;

· If a brand name is cited, supply the manufacturer's name and address (city and state/country);

· Species names should be in italics.

Tables and figures

· No repetition of data in tables and graphs and in text;

· Actual numbers from which graphs drawn, provided;

· Figures necessary and of good quality (color);

· Table and figure numbers in Arabic letters (not Roman);

· Figure legends provided;

· Patients' privacy maintained (if not permission taken);

· Credit note for borrowed figures/tables provided;

· Write the full term for each abbreviation used in the table as a footnote.

Additional resources

· ICMJE: http://www.icmje.org.

· Equator Network: Enhancing the Quality and Transparency of Health Research: http://www.equator-network.org/.

· COPE: http://publicationethics.org/.

How to submit 

All manuscripts must be submitted online at: https://www.editorialmanager.com/idi

Pre-submission enquiries

First-time users

Please click the Register button at https://www.editorialmanager.com/idi. Upon successful registration, you will be sent an email providing your username and password. Save this information for future reference. Note: If you have received an email from us with an assigned username and password, or if you are a repeat user, do not register again. Once you have an assigned username and password, you do not have to re-register.

Authors

Please click the Login button from the menu at the top of the page and login to the system as an author. Submit your manuscript according to the author instructions. You will be able to track the process of your manuscript through the system.

Online Submission

Once the manuscript has been created, visit the submission site at https://www.editorialmanager.com/idi to upload the manuscript. Once the manuscript has been vetted for compliance to the Journal's requirements, a manuscript number will be assigned to the submission. Failure to adhere to these guidelines will result in your manuscript being returned to you for correction. Faxed, scanned or emailed copies of manuscripts will not be accepted.

Revised Submissions

Mandatory Author Forms

Upon first revision, authors will be required to complete a License to Publish (LTP) form. LTP forms are required of every author listed on the submission. Please ensure each author's email address is properly listed on the footnotes page of your manuscript to avoid delays in reaching authors. Manuscripts will not pass to production without completed forms. LTP forms are available from the submission site homepage https://www.idi.org.

All revised submissions require a point-by-point response to the reviewers' comments. Please upload this document as file type Response to Reviewers.

Changes made in the revised manuscript should be indicated using highlighted, bold or underlined text. Upload both a Marked and a Clean version of the revised manuscript. File types are provided for both versions.

A requirement of all revisions is the artwork quality check as described above (see Figures and Legends).

Revised manuscripts should be submitted within the deadline specified in the decision letter. Please contact us for an extension of the due date if it is not possible to submit the revision within that period, or should you desire to withdraw the manuscript from further consideration.

Revisions should adhere to original specifications for the submission type. Sometimes changes made in response to the decision/critiques may bring the revised manuscript out of compliance (e.g., over the word count and/or table/figure limit) with original specifications. This may be allowed by the Editor, but must be noted in the point-by-point response.

Submitting Invited Videos

Authors may want or be invited to submit videos to the Journal's website. The videos will serve to emphasize key aspects of the research findings reported in their soon to be published manuscript. Please visit Stand Alone Video Format Requirements http://bit.ly/VMxbrbto download full specifications and instructions for preparing these invited videos.

Post acceptance

Page Proofs

The publisher's Journal Production Editor will contact you when page proofs are ready for your review. The figures included on author's proofs are high resolution. Please inform the Journal Production Editor immediately if you have any questions concerning the quality of the figures on the proofs. For information regarding proofs, or the status of publication of your accepted manuscript, please contact editorial office, email: idi@cmaph.org.

Changes in Corresponding Author's Contact Information

Please give all new information, including email address, to the editorial office and to the publisher. Authors may send this information to editorial office, email: idi@cmaph.org. If the Journal is unsuccessful in contacting the corresponding author, the author will not receive proofs for approval, and the manuscript may not be published.

Changes at Proofs

It is expected that the final manuscript sent to the Editor is indeed the final version, so few changes should be required at proof stage.

Copyright

The Chinese Medical Association (CMA) is the owner of all copyrights to any articles published in the journal. Published manuscripts become the permanent property of CMA and may not be published elsewhere without written permission. CMA keeps the right to use these manuscripts in any form, including print, video, audio and digital.

Open Access

Every peer-reviewed research article appearing in this journal will be published open access. This means that the article is universally and freely accessible via the internet in perpetuity, in an easily readable format immediately after publication. The journal does not charge for submission, processing or publication of manuscripts and even for color reproduction of photographs. The Chinese Medical Association will pay to make the article open access.

Creative Commons Licenses

Open access articles will be freely available to read, download and share from the time of publication. Articles are published under the terms of the Creative Commons License Attribution-Non Commerical No Derivative 4.0 which allows readers to disseminate and reuse the article, as well as share and reuse of the scientific material. It does not permit commercial exploitation or the creation of derivative works without specific permission. To view a copy of this license visit
http://creativecommons.org/licenses/by-nc-nd/4.0

Journal policies

Duplicate Publication

Manuscripts are reviewed for possible publication with the understanding that they are being submitted only to IDI and have not been published, simultaneously submitted, or already accepted for publication elsewhere. The Editorial team may subject any manuscript submitted for consideration of publication in IDI to plagiarism-detection software.

This does not preclude consideration of a manuscript that has been rejected by another journal or a complete report that follows publication of preliminary findings elsewhere, usually in the form of an abstract. Copies of any possibly duplicate published material should be submitted with the manuscript under consideration, with a statement in the cover letter as to why the manuscript currently being submitted is not a duplicate publication.

Disclosure of Conflicts

Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading "Conflicts of Interest" and "Funding". For example: "Conflicts of Interest: A has received honoraria from Company Z. B is on the speaker's bureau for Organization X - the CME organizers for Company A. For the remaining authors none were declared."

Financial Support and Competing Interests

A financial disclosure section is part of the submission process and must be completed by each author at first submission. This information is for review by the Editors but will be published if relevant to the content of the accepted manuscript.

The primary purpose of the disclosure section is to determine whether authors have received any commercial financial support that could create a conflict of interest. In addition to monetary interests, a potential for conflict of interest can exist whether or not an individual believes that a relationship (such as dual commitments, competing interests, or competing loyalties) affects his or her scientific judgment. Please review ICMJE Uniform Requirements for Manuscripts Submitted to Biomedical Journals at the following link: http://www.icmje.org/conflicts-of-interest.

Authorship

IDI expects that each person listed as an author has participated sufficiently in the intellectual content, the analysis of data, and/or the writing of the manuscript to take public responsibility for it. Each author must have reviewed the manuscript, believes it represents valid work, and approves it for submission.

Moreover, should the Editorial team request the data upon which the manuscript is based, the authors shall provide the data. Each author's specific contributions to the work should be indicated; this information will be published as a footnote to the paper. For example, the areas of participation might include:

· Participated in research design

· Participated in the writing of the paper

· Participated in the performance of the research

· Contributed new reagents or analytic tools

· Participated in data analysis

An author may list more than one contribution, and more than one author may have contributed to the same aspect of the work. Any change in authorship/contributions after submission must be approved in writing by all authors and submitted to the Editorial Office for final consideration.

Retraction Policy

IDI should consider retracting a publication if:

· Editors have clear evidence that the findings are unreliable, either as a result of misconduct (e.g., data fabrication) or honest error (e.g., miscalculation or experimental error).

· The findings have previously been published elsewhere without proper cross referencing, permission or justification (i.e., cases of redundant publication).

· It constitutes plagiarism.

· It reports unethical research.

· IDI abides by Retraction Guidelines of the Committee on Publication Ethics (COPE) (http://publicationethics.org/files/retraction%20guidelines_0.pdf).

Reporting of Randomized Clinical Trials

Registration of Clinical Trials is an essential requirement for publication of clinical trials in Infectious Diseases & Immunity. On the title page of your manuscript, provide the name of the trial registry and the registration number/identifier of the trial.

Acceptable web-based clinical trial registries include the following:

· EudraCT at https://eudract.ema.europa.eu for EU trials

· Clinical Trials at www.clinicaltrials.gov for US trials

· Current Controlled Trials found at www.controlled-trials.com

· WHO International Trial Registry Networkfound at http://www.who.int/ictrp/network/primary/en/index.html

· Australian & New Zealand Clinical Trials Registry, found at http://www.anzctr.org.au/

· And any publicly available primary registry of clinical trials

Reports of randomized clinical trials should follow the recommendations given in the Consolidated Standards of Reported Trials (CONSORT) statement http://www.consort-statement.org.In brief, this statement comprises a checklist and flow diagram to help improve the quality of reports of randomized controlled trials and offers a standard way for researchers to report trials.

Optional Reporting Guidelines

The following resources may be helpful to authors:

· PRISMA –Preferred Reporting Items for Systematic Reviews and Meta-Analyses http://www.prisma-statement.org

· STROBE - Strengthening the Reporting of Observational studies in Epidemiology http://www.strobe-statement.org

· STEGA - Strengthening the Reporting of Genetic Associations http://www.med.uottawa.ca/public-health-genomics/web/eng/strega.html

Qualitative Research

Qualitative research provides in-depth insights about people's values, attitudes, beliefs, and experiences. Qualitative methodology informs approaches to data collection and analysis, and includes grounded theory, ethnography, and phenomenology. Open-ended interviews and focus groups are commonly used to collect data. Authors are advised to follow the COREQ guidelines for reporting primary qualitative research. Please visit: http://intqhc.oxfordjournals.org/content/19/6/349.full.pdf

Systematic review and/or synthesis of primary qualitative studies can provide a broader understanding of people's perspectives across different healthcare contexts. Methodologies for synthesis of qualitative research include thematic synthesis, meta-ethnography and critical interpretive synthesis. Authors can refer to the ENTREQ statement at
http://www.biomedcentral.com/content/pdf/1471-2288-12-181.pdf

Peer Review

All articles published in IDI are subject to review by the Editorial team. Authors submitting manuscripts to IDI propose suitable reviewers or oppose reviewers who may have competing interests. Manuscripts are accepted on the basis of quality, originality, significance, novelty and interest to the readers of IDI. A paper that has been formally rejected will not be reconsidered for publication in IDI.

Ethics and Consent

Ethics approval

Research involving human participants, human material, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in all manuscripts reporting such research.. Manuscripts may be rejected if the Editor considers that the research has not been carried out within an appropriate ethical framework.

Consent to participate

For all research involving human participants, informed consent to participate in the study should be obtained from participants (or their parent or legal guardian in the case of children under 16) and a statement to this effect should appear in the manuscript.

Protection of Patients' Rights to Privacy

Identifying information should not be published in written descriptions, photographs, sonograms, CT scans, etc., and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian, wherever applicable) gives written informed consent for publication. Authors should remove patients' names from figures unless they have obtained written informed consent from the patients. IDI abides by ICMJE guidelines: (1) Authors, not the journals nor the publisher, need to have the patient consent form before the publication related to patient privacy and have the form properly archived by the author. (2) If the publication includes some facial images that make the patients identifiable, a statement about the patient's consent needs to be present in the manuscript.

Further information

The Editorial Office is pleased to answer any questions you may have about preparing your manuscript in accordance with our guidelines. Email: idi@cmaph.org.

Submit a manuscript: https://www.editorialmanager.com/idi.